Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Polymer-Mediated Delivery of siRNAs to Hepatocellular Carcinoma: Variables Affecting Specificity and Effectiveness

R. Farra, F. Musiani, F. Perrone, M. Čemažar, U. Kamenšek, F. Tonon, M. Abrami, A. Ručigaj, M. Grassi, G. Pozzato, D. Bonazza, F. Zanconati, G. Forte, M. El Boustani, L. Scarabel, M. Garziera, C. Russo Spena, L. De Stefano, B. Salis, G. Toffoli,...

. 2018 ; 23 (4) : . [pub] 20180328

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc18033210

Despite the advances in anticancer therapies, their effectiveness for many human tumors is still far from being optimal. Significant improvements in treatment efficacy can come from the enhancement of drug specificity. This goal may be achieved by combining the use of therapeutic molecules with tumor specific effects and delivery carriers with tumor targeting ability. In this regard, nucleic acid-based drug (NABD) and particularly small interfering RNAs (siRNAs), are attractive molecules due to the possibility to be engineered to target specific tumor genes. On the other hand, polymeric-based delivery systems are emerging as versatile carriers to generate tumor-targeted delivery systems. Here we will focus on the most recent findings in the selection of siRNA/polymeric targeted delivery systems for hepatocellular carcinoma (HCC), a human tumor for which currently available therapeutic approaches are poorly effective. In addition, we will discuss the most attracting and, in our opinion, promising siRNA-polymer combinations for HCC in relation to the biological features of HCC tissue. Attention will be also put on the mathematical description of the mechanisms ruling siRNA-carrier delivery, this being an important aspect to improve effectiveness reducing the experimental work.

C R O National Cancer Institute via Franco Gallini 2 1 33081 Aviano Italy

Center for Translational Medicine St Anne's University Hospital Studenstka 6 656 91 Brno Czech Republic

Department of Engineering and Architecture University of Trieste Via Alfonso Valerio 6 A 1 34127 Trieste Italy

Department of Experimental Oncology Institute of Oncology Ljubljana Zaloska 2 SI 1000 Ljubljana Slovenia

Department of Experimental Oncology Institute of Oncology Ljubljana Zaloska 2 SI 1000 Ljubljana Slovenia Faculty of Health Sciences University of Primorska Polje 42 SI 6310 Izola Slovenia

Department of Life Sciences Cattinara University Hospital Trieste University Strada di Fiume 447 1 34149 Trieste Italy

Department of Life Sciences Cattinara University Hospital Trieste University Strada di Fiume 447 1 34149 Trieste Italy Faculty of Chemistry and Chemical Technology University of Ljubljana Večna pot 113 SI 1000 Ljubljana Slovenia

Department of Scienze Mediche Chirurgiche e della Salute University of Trieste Cattinara Hospital Strada di Fiume 447 1 34149 Trieste Italy

Experimental and Clinical Pharmacology Unit C R O National Cancer Institute via Franco Gallini 2 1 33081 Aviano Italy

Experimental and Clinical Pharmacology Unit C R O National Cancer Institute via Franco Gallini 2 1 33081 Aviano Italy Doctoral School in Chemistry University of Trieste 34100 Trieste Italy

Experimental and Clinical Pharmacology Unit C R O National Cancer Institute via Franco Gallini 2 1 33081 Aviano Italy Doctoral School in Molecular Biomedicine University of Trieste 34100 Trieste Italy

Faculty of Chemistry and Chemical Technology University of Ljubljana Večna pot 113 SI 1000 Ljubljana Slovenia

Laboratory of Bioinorganic Chemistry Department of Pharmacy and Biotechnology University of Bologna 1 40127 Bologna Italy

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18033210
003      
CZ-PrNML
005      
20181010124955.0
007      
ta
008      
181008s2018 sz f 000 00|eng||
009      
AR
024    7_
$a 10.3390/molecules23040777 $2 doi
035    __
$a (PubMed)29597300
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Farra, Rossella $u Department of Engineering and Architecture, University of Trieste, Via Alfonso Valerio, 6/A, I-34127 Trieste, Italy. rfarra@units.it.
245    10
$a Polymer-Mediated Delivery of siRNAs to Hepatocellular Carcinoma: Variables Affecting Specificity and Effectiveness / $c R. Farra, F. Musiani, F. Perrone, M. Čemažar, U. Kamenšek, F. Tonon, M. Abrami, A. Ručigaj, M. Grassi, G. Pozzato, D. Bonazza, F. Zanconati, G. Forte, M. El Boustani, L. Scarabel, M. Garziera, C. Russo Spena, L. De Stefano, B. Salis, G. Toffoli, F. Rizzolio, G. Grassi, B. Dapas,
520    9_
$a Despite the advances in anticancer therapies, their effectiveness for many human tumors is still far from being optimal. Significant improvements in treatment efficacy can come from the enhancement of drug specificity. This goal may be achieved by combining the use of therapeutic molecules with tumor specific effects and delivery carriers with tumor targeting ability. In this regard, nucleic acid-based drug (NABD) and particularly small interfering RNAs (siRNAs), are attractive molecules due to the possibility to be engineered to target specific tumor genes. On the other hand, polymeric-based delivery systems are emerging as versatile carriers to generate tumor-targeted delivery systems. Here we will focus on the most recent findings in the selection of siRNA/polymeric targeted delivery systems for hepatocellular carcinoma (HCC), a human tumor for which currently available therapeutic approaches are poorly effective. In addition, we will discuss the most attracting and, in our opinion, promising siRNA-polymer combinations for HCC in relation to the biological features of HCC tissue. Attention will be also put on the mathematical description of the mechanisms ruling siRNA-carrier delivery, this being an important aspect to improve effectiveness reducing the experimental work.
650    _2
$a zvířata $7 D000818
650    12
$a hepatocelulární karcinom $x farmakoterapie $x genetika $x metabolismus $x patologie $7 D006528
650    _2
$a lékové transportní systémy $x metody $7 D016503
650    _2
$a lidé $7 D006801
650    12
$a nádory jater $x farmakoterapie $x genetika $x metabolismus $x patologie $7 D008113
650    12
$a biologické modely $7 D008954
650    _2
$a chemické modely $7 D008956
650    12
$a polymery $x chemie $x terapeutické užití $7 D011108
650    12
$a malá interferující RNA $x chemie $x genetika $x terapeutické užití $7 D034741
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Musiani, Francesco $u Laboratory of Bioinorganic Chemistry, Department of Pharmacy and Biotechnology, University of Bologna, I-40127 Bologna, Italy. Francesco.musiani@unibo.it.
700    1_
$a Perrone, Francesca $u Department of Life Sciences, Cattinara University Hospital, Trieste University, Strada di Fiume 447, I-34149 Trieste, Italy. Francesca.Perrone@phd.units.it.
700    1_
$a Čemažar, Maja $u Department of Experimental Oncology, Institute of Oncology, Ljubljana, Zaloska 2, SI-1000 Ljubljana, Slovenia. MCemazar@onko-i.si. Faculty of Health Sciences, University of Primorska, Polje 42, SI-6310 Izola, Slovenia. MCemazar@onko-i.si.
700    1_
$a Kamenšek, Urška $u Department of Experimental Oncology, Institute of Oncology, Ljubljana, Zaloska 2, SI-1000 Ljubljana, Slovenia. UKamensek@onko-i.si.
700    1_
$a Tonon, Federica $u Department of Life Sciences, Cattinara University Hospital, Trieste University, Strada di Fiume 447, I-34149 Trieste, Italy. effetonon@gmail.com.
700    1_
$a Abrami, Michela $u Department of Engineering and Architecture, University of Trieste, Via Alfonso Valerio, 6/A, I-34127 Trieste, Italy. Michela.Abrami@dia.units.it.
700    1_
$a Ručigaj, Aleš $u Faculty of Chemistry and Chemical Technology, University of Ljubljana, Večna pot 113, SI-1000 Ljubljana, Slovenia. Ales.Rucigaj@fkkt.uni-lj.si.
700    1_
$a Grassi, Mario $u Department of Engineering and Architecture, University of Trieste, Via Alfonso Valerio, 6/A, I-34127 Trieste, Italy. mario.grassi@dia.units.it.
700    1_
$a Pozzato, Gabriele $u Department of "Scienze Mediche, Chirurgiche e della Salute", University of Trieste, Cattinara Hospital, Strada di Fiume 447, I-34149 Trieste, Italy. G.POZZATO@fmc.units.it.
700    1_
$a Bonazza, Deborah $u Department of "Scienze Mediche, Chirurgiche e della Salute", University of Trieste, Cattinara Hospital, Strada di Fiume 447, I-34149 Trieste, Italy. deborah.bonazza@asuits.sanita.fvg.it.
700    1_
$a Zanconati, Fabrizio $u Department of "Scienze Mediche, Chirurgiche e della Salute", University of Trieste, Cattinara Hospital, Strada di Fiume 447, I-34149 Trieste, Italy. fabrizio.zanconati@asuits.sanita.fvg.it.
700    1_
$a Forte, Giancarlo $u Center for Translational Medicine (CTM), International Clinical Research Center (ICRC), St. Anne's University Hospital, Studenstka 6, 656 91 Brno, Czech Republic. giancarlo.forte@fnusa.cz.
700    1_
$a El Boustani, Maguie $u Experimental and Clinical Pharmacology Unit, C.R.O.-National Cancer Institute, via Franco Gallini 2, I-33081 Aviano (PN), Italy. elboustanymaguie@gmail.com. Doctoral School in Molecular Biomedicine, University of Trieste, 34100 Trieste, Italy. elboustanymaguie@gmail.com.
700    1_
$a Scarabel, Lucia $u C.R.O.-National Cancer Institute, via Franco Gallini 2, I-33081 Aviano (PN), Italy. lucia.scarabel@cro.it.
700    1_
$a Garziera, Marica $u Experimental and Clinical Pharmacology Unit, C.R.O.-National Cancer Institute, via Franco Gallini 2, I-33081 Aviano (PN), Italy. mgarziera@cro.it.
700    1_
$a Russo Spena, Concetta $u Experimental and Clinical Pharmacology Unit, C.R.O.-National Cancer Institute, via Franco Gallini 2, I-33081 Aviano (PN), Italy. concettarussospena@gmail.com. Doctoral School in Chemistry, University of Trieste, 34100 Trieste, Italy. concettarussospena@gmail.com.
700    1_
$a De Stefano, Lucia $u Experimental and Clinical Pharmacology Unit, C.R.O.-National Cancer Institute, via Franco Gallini 2, I-33081 Aviano (PN), Italy. lucia.destefano077@gmail.com. Doctoral School in Chemistry, University of Trieste, 34100 Trieste, Italy. lucia.destefano077@gmail.com.
700    1_
$a Salis, Barbara $u Experimental and Clinical Pharmacology Unit, C.R.O.-National Cancer Institute, via Franco Gallini 2, I-33081 Aviano (PN), Italy. salis.barbara@libero.it. Doctoral School in Molecular Biomedicine, University of Trieste, 34100 Trieste, Italy. salis.barbara@libero.it.
700    1_
$a Toffoli, Giuseppe $u Experimental and Clinical Pharmacology Unit, C.R.O.-National Cancer Institute, via Franco Gallini 2, I-33081 Aviano (PN), Italy. gtoffoli@cro.it.
700    1_
$a Rizzolio, Flavio $u Experimental and Clinical Pharmacology Unit, C.R.O.-National Cancer Institute, via Franco Gallini 2, I-33081 Aviano (PN), Italy. flavio.rizzolio@unive.it. Department of Molecular Sciences and Nanosystems, Ca' Foscari University, via Torino 155, I-30172 Mestre (Venezia), Italy. flavio.rizzolio@unive.it.
700    1_
$a Grassi, Gabriele $u Department of Life Sciences, Cattinara University Hospital, Trieste University, Strada di Fiume 447, I-34149 Trieste, Italy. ggrassi@units.it. Faculty of Chemistry and Chemical Technology, University of Ljubljana, Večna pot 113, SI-1000 Ljubljana, Slovenia. ggrassi@units.it.
700    1_
$a Dapas, Barbara $u Department of Life Sciences, Cattinara University Hospital, Trieste University, Strada di Fiume 447, I-34149 Trieste, Italy. bdapas@units.it.
773    0_
$w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 23, č. 4 (2018)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29597300 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20181008 $b ABA008
991    __
$a 20181010125444 $b ABA008
999    __
$a ok $b bmc $g 1340846 $s 1030204
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 23 $c 4 $e 20180328 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
LZP    __
$a Pubmed-20181008

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace